Debrisoquin (hydrobromide)
Debrisoquine (Ro 5-3307/1) hydrobromide is a TMPRSS2 inhibitors that inhibits SARS-CoV-2 entry into human lung cell line by a TMPRSS2-depedent manner, with an IC50 of 22μM. Debrisoquine hydrobromide can be used for antiviral research[1].
Product Specifications
CAS Number
1131-65-3
Product Name Alternative
Debrisoquine (hydrobromide) ; Isocaramidine (hydrobromide) ; Ro 5-3307/1 (hydrobromide)
UNSPSC
12352005
Target
SARS-CoV; Ser/Thr Protease
Related Pathways
Anti-infection; Metabolic Enzyme/Protease
Applications
COVID-19-anti-virus
Field of Research
Infection
Smiles
N=C(N1CC2=C(CC1)C=CC=C2)N.Br
Molecular Formula
C10H14BrN3
Molecular Weight
256.14
References & Citations
[1]Amanda L. Peiffer, et.al.TMPRSS2 Inhibitor Discovery Facilitated through an In Silico and Biochemical Screening Platform.ACS Medicinal Chemistry Letters 2023 14 (6), 860-866.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS189915-01 0.01 mg
Human 5HT1E full length protein-synthetic nanodisc
Sign In for Pricing
View Details MBS189915-02 0.05 mg
Human 5HT1E full length protein-synthetic nanodisc
Sign In for Pricing
View Details MBS189915-03 0.1 mg
Human 5HT1E full length protein-synthetic nanodisc
Sign In for Pricing
View Details 
MBS4381329-01 0.02 mg (With BSA & Azide at 0.2mg/mL)
Uroplakin 1B (Urothelial Differentiation Marker)
Sign In for Pricing
View Details